Krish Patel, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Lilly
    Topic:
    CLL/Lymphoma
    Date added:
    02/09/2023
    Date updated:
    03/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Topic:
    Lymphoma
    Date added:
    02/09/2023
    Date updated:
    03/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    ADC Therapeutics
    Topic:
    Lymphoma
    Date added:
    02/09/2023
    Date updated:
    03/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Xencor
    Topic:
    Lymphoma
    Date added:
    02/09/2023
    Date updated:
    03/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sana
    Topic:
    Cellular Therapy
    Date added:
    03/21/2024
    Date updated:
    03/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Merck
    Topic:
    Lymphoma
    Date added:
    03/21/2024
    Date updated:
    03/21/2024

Pages

Return to 2024 Summit on Hematological Cancers